Nation Jan 05 Can Florida’s plan to import drugs from Canada lower medication costs? By Lisa Desjardins, Karina Cuevas
Health Jul 08 FDA trims use of contentious Alzheimer’s drug amid backlash The Food and Drug Administration has approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer's drug. By Matthew Perrone, Associated Press
Health Jun 07 Watch 6:00 Why the FDA approved a controversial Alzheimer’s drug The FDA on Monday approved the first new drug to treat Alzheimer's disease in nearly two decades. Federal health officials said it may help slow the brain-destroying disease's progression, but the approval goes against the agency's independent advisers who said… By Amna Nawaz, Claire Mufson
Health Jan 03 How to spot deceptive drug injury ads like the ones Facebook just disabled Some ads can be more than misleading – they can put your health at risk. By Elizabeth C. Tippett, Jesse King, The Conversation
Health Aug 26 Watch 8:01 What Okla. judgment against Johnson & Johnson means for opioid accountability An Oklahoma judge delivered a $572 million judgment against pharmaceutical giant Johnson & Johnson in the first major legal decision to go against a drugmaker for its role in the opioid crisis. The judge found the company’s marketing practices helped…
Aug 22 Nonprofit drug maker produces TB antibiotic after private companies wouldn’t By Zoe Rohrich The new antibiotic, called pretomanid and developed by the nonprofit TB Alliance, achieved a 90 percent success rate among patients with drug-resistant TB. Continue reading
Dec 14 Watch 7:50 Fighting the public health threat of counterfeit drugs By Fred de Sam Lazaro Fake pharmaceuticals are a multi-billion dollar problem around the world. Made and packaged to look like the real deal, these phonies may contain a fraction of the active ingredients or none at all. these fake drugs can have serious consequences… Continue watching
Apr 24 Why kid-friendly medications can be expensive for parents By Shefali Luthra, Kaiser Health News When prescribing medications, caring for children poses a particular challenge. They’re not just little adults. Their still-developing brains and bodies metabolize drugs differently, and what works for grown-ups can yield radically different — and sometimes dangerous — results in kids. Continue reading
Jan 13 Tom Price, Trump’s HHS nominee, got a sweetheart deal from a foreign biotech firm By Jay Hancock and Rachel Bluth, Kaiser Health News When Australian biotech firm Innate Immunotherapeutics needed to raise money last summer, it offered a sweetheart deal to “sophisticated U.S. investors.” One of them was Rep. Tom Price. Continue reading
Dec 03 Investments by Trump’s HHS pick raise questions over conflict of interest By Sheila Kaplan, STAT Trump's nominee to be secretary of health and human services, Rep. Tom Price, could have conflicts of his own. Continue reading